한글목차

세계 두경부암 진단 시장의 미래는 병원, 외래수술센터(ASC), 진단센터 시장에 기회가 있고 유망합니다. 세계 두경부암 진단 시장 규모는 2025-2031년 7.1%의 연평균 복합 성장률(CAGR)로 2031년까지 약 34억 달러에 달할 것으로 예측됩니다. 이 시장의 주요 촉진요인은 두경부암의 유병률 증가, 의료 서비스 접근성 향상, 두경부암의 징후와 증상, 조기 발견의 중요성에 대한 인식 증가 등입니다.

• Lucintel의 예측에 따르면, 진단별로는 영상진단이 예측 기간 동안 가장 높은 성장세를 보일 것으로 예측됩니다.
• 최종 용도별로는 병원이 질병 진단 능력이 뛰어나고 최신 의료 장비와 기술을 갖추고 있어 환자에게 최상의 치료를 제공할 수 있기 때문에 병원이 가장 큰 부문이 될 것으로 보입니다.
• 지역별로 보면, 북미는 강력한 헬스케어 인프라, 유리한 상환 정책, 질병에 대한 높은 인지도, 헬스케어 부문 발전에 대한 정부 지원으로 인해 예측 기간 동안 가장 규모가 큰 지역으로 남을 것으로 보입니다.

두경부암 진단 시장에서의 전략적 성장 기회

두경부암 진단 시장은 다양한 용도에 걸쳐 다양한 성장 기회를 제공합니다. 이러한 기회를 이해함으로써 이해관계자들은 투자 및 개발 분야를 선택할 수 있습니다.

• 분자진단: 분자진단 검사에 대한 수요 증가는 시장에 큰 기회를 제공합니다. 이러한 검사는 두경부암을 조기에 발견하고 분류할 수 있으며, 효과적인 치료에 필요한 중요한 정보를 제공합니다.
• AI 강화 영상 솔루션: 의료 전문가들은 진단 정확도를 향상시키는 AI 강화 영상 솔루션이 필요합니다. 이러한 기술은 높은 잠재력을 가지고 있으며, 진단 효율성과 환자 관리를 강화하기 위해 개발 및 시장 개척이 가능합니다.
• 액체 생검 응용 분야: 액체 생검(액체 생검) 응용 분야 확대는 수익 성장을 가속할 것입니다. 조기 진단 및 치료 평가를 위한 비침습적 검사가 빠르게 부상하고 있으며, 환자와 서비스 제공업체 모두에게 이익이 됩니다.
• 원격의료와의 통합: 원격의료의 통합은 진단 서비스를 원격으로 제공함으로써 본격적인 성장 기회를 제공합니다. 원격 진단 도구 시장 확대는 특히 원격지에서의 환자 치료를 개선할 수 있습니다.
• 공동 연구 노력: 학술 연구 기관과 임상 연구 기관의 협업은 시장성 있는 진단 도구와 기술의 신속한 개발로 이어집니다. 이러한 이니셔티브는 기업이 시장 경쟁력을 강화하는 데 도움이 됩니다.

이러한 전략적 성장 기회는 두경부암 진단 시장의 새로운 격차를 해소하고, 이해관계자들이 환자 관리와 시장 경쟁을 강화하는 혁신적인 솔루션을 개발할 수 있는 기회를 제공합니다.

두경부암 진단 시장 성장 촉진요인 및 과제

시장 성장 촉진요인으로는 진단 기술의 발전, 암 검진 및 치료에 대한 일반 대중의 인식 증가, 의료 예산 증가 등을 들 수 있습니다. 반면, 규제 장벽, 고가의 진단 방법, 일부 지역에서는 특정 기술이 부족하다는 점 등이 장애요인으로 작용할 수 있습니다.

두경부암 진단 시장 성장 촉진요인은 다음과 같습니다.

• 기술 발전: 진단 서비스 시장은 기존 검사와 새로운 분자 기반 검사의 지속적인 발전으로 진화하고 있습니다. 이러한 발전은 두경부암 진단의 효율성과 타이밍을 개선하여 진단 절차에 대한 수요 증가로 이어지고 있습니다.
• 암 교육 범위 확대: 공중보건 캠페인으로 두경부암을 포함한 암의 조기 발견에 대한 인식이 높아지고 있습니다. 이에 따라 검진 및 진단을 받는 사람들이 증가하고 있습니다.
• 의료비 지출 증가: 신흥 시장에서는 의료비 지출이 증가하고 있으며, 이는 진단 도구에 대한 투자로 이어지고 있습니다. 이들 시장의 의료 기관들은 새로운 진단 장비를 도입하여 양질의 의료 서비스에 대한 접근성을 향상시키고 시장 성장을 가속하고 있습니다.
• 노인 인구 증가: 고령화는 두경부암의 유병률 증가에 기여하고 있습니다. 노인 인구 증가는 진단 서비스에 대한 수요를 증가시켜 시장 성장의 또 다른 원동력이 되고 있습니다.
• 표적 치료 프로그램: 더 많은 표적 치료법이 개발됨에 따라 이러한 치료법에 적합한 고급 진단 도구에 대한 수요가 증가하고 있습니다. 환자별 건강 상태에 따라 암을 진단하는 것은 맞춤형 진단 도구의 필요성을 증가시킵니다.

두경부암 진단 시장의 과제는 다음과 같습니다.

• 고가의 첨단 진단 도구: 새로운 진단 장비는 종종 고가이며, 자원이 부족한 지역에서는 사용이 제한됩니다. 그 결과, 진단과 치료가 지연되고 회복이 지연될 수 있습니다.
• 규제 준수에 따른 과제: 진단 의약품 시장의 복잡한 규제를 극복하는 것은 기업에게 큰 도전이 될 수 있습니다. 다양한 기준과 법률을 준수하는 것은 비용이 많이 들고, 신제품 시장 진입을 지연시킬 수 있습니다.
• 첨단 진단 기술에 대한 접근성 제한: 많은 지역, 특히 개발도상국에서는 첨단 진단 기술에 대한 접근성이 제한되어 있습니다. 이는 조기 발견율의 저하와 의료의 질 저하로 이어질 수 있으며, 적절한 솔루션으로 해결해야 합니다.

두경부암 진단 시장은 촉진요인과 도전 요인에 의해 형성되고 있습니다. 이해관계자들이 성장 기회를 활용하고 시장 수요를 충족시키는 솔루션을 제공하기 위해서는 이러한 요인을 이해하는 것이 매우 중요합니다.

목차

제1장 주요 요약

제2장 세계의 두경부암 진단 시장 : 시장 역학

• 서론, 배경, 분류
• 공급망
• 업계 촉진요인과 과제

제3장 시장 동향과 예측 분석(2019년-2031년)

• 거시경제 동향(2019년-2024년)과 예측(2025년-2031년)
• 세계의 두경부암 진단 시장 동향(2019-2024년)과 예측(2025-2031년)
• 세계의 두경부암 진단 시장 : 유형별
  • 후두암
  • 인두암
  • 침샘암
  • 입술 및 구강암
  • 비인두암
  • 기타
• 세계의 두경부암 진단 시장 : 진단별
  • 생체 검사 선별검사
  • 혈액 검사
  • 치과 진단
  • 영상 진단
  • 내시경 검사
• 세계의 두경부암 진단 시장 : 치료별
  • 화학요법
  • 방사선 치료
  • 표적치료
  • 수술
  • 기타
• 세계의 두경부암 진단 시장 : 최종 용도별
  • 병원
  • 외래수술센터(ASC)
  • 진단센터
  • 기타

제4장 시장 동향과 예측 분석 : 지역별(2019년-2031년)

• 세계의 두경부암 진단 시장 : 지역별
• 북미의 두경부암 진단 시장
• 유럽의 두경부암 진단 시장
• 아시아태평양의 두경부암 진단 시장
• 기타 지역의 두경부암 진단 시장

제5장 경쟁 분석

• 제품 포트폴리오 분석
• 운영 통합
• Porter의 Five Forces 분석

제6장 성장 기회와 전략 분석

• 성장 기회 분석
  • 세계의 두경부암 진단 시장 성장 기회 : 유형별
  • 세계의 두경부암 진단 시장 성장 기회 : 진단별
  • 세계의 두경부암 진단 시장 성장 기회 : 치료별
  • 세계의 두경부암 진단 시장 성장 기회 : 최종 용도별￥
  • 세계의 두경부암 진단 시장 성장 기회 : 지역별
• 세계 두경부암 진단 시장의 새로운 동향
• 전략 분석
  • 신제품 개발
  • 세계의 두경부암 진단 시장 캐파시티 확대
  • 세계 두경부암 진단 시장에서의 인수합병(M&A) 및 합작투자(JV)
  • 인증 및 라이선싱

제7장 주요 기업 개요

• GE Healthcare
• Philips
• Siemens Healthineers
• Merck
• Eli Lilly

영문목차

The future of the global head and neck cancer diagnostic market looks promising with opportunities in the hospital, ambulatory surgical center, and diagnostic center markets. The global head and neck cancer diagnostic market is expected to reach an estimated 3.4 billion by 2031 with a CAGR of 7.1% from 2025 to 2031. The major drivers for this market are the increasing prevalence of head and neck cancer, surfing access to healthcare, and growing awareness of the signs and symptoms of head and neck cancer, as well as the importance of early detection.

• Lucintel forecasts that, within the diagnosis category, imaging is expected to witness the highest growth over the forecast period.
• Within the end use category, hospitals will remain the largest segment because it has better disease diagnosis capabilities and also has the latest medical equipment and technology, which allows them to provide patients with the best possible care.
• In terms of regions, North America will remain the largest region during the forecast period due to the presence of a strong healthcare infrastructure, favorable reimbursement policies, high awareness about the disease, and government support for the development of the healthcare sector.

Gain Valuable insights for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Head and Neck Cancer Diagnostic Market

The head and neck cancer diagnostic market is changing rapidly, and there are trends that will determine its future. These trends involve new ways of diagnosing and managing patients, as well as new treatment options.

• Liquid Biopsy Development: Head and neck cancers may be diagnosed at an earlier stage when biopsies are not compatible with surgery. Liquid biopsies are becoming an accepted method of non-invasive tumor identification. They evaluate tumor cells in the bloodstream, providing both diagnosis and responses to treatment sooner than otherwise possible. This phenomenon is changing modern oncology by providing real-time information about tumor growth and response to therapy.
• Artificial Intelligence in Diagnostics: There is a growing trend towards enhancing head and neck cancer diagnostics through artificial intelligence and machine learning. AI algorithms can assist individuals without prior training to review CT or MR imaging studies and analyze clinical data, thus enhancing clinical decision-making. This technology improves accuracy and efficiency in analyzing images, which are often time-consuming.
• Personalization of Medicine Gaining Momentum: The increasing use of personalized medicine is driving a new trend toward personalized diagnostics and treatment methods. Genetic and molecular profiling helps determine distinct biomarkers for head and neck cancers, enabling targeted treatment that is more effective and less harmful.
• Telemedicine and Remote Diagnostic Interfaces: The use of telemedicine for diagnosing head and neck cancers is increasing, particularly in rural and underserved areas. Patients can be treated remotely by monitoring their symptoms and providing timely interventions, which alleviates the burden on healthcare facilities. This expansion helps with early diagnosis of cancers.
• Growing Cooperation between Academia and Industry: The collaboration between research centers and companies is becoming more active, with the goal of improving head and neck cancer diagnosis. These partnerships aim to foster the invention of better diagnostic tools, benefiting both the healthcare sector and the business environment.

Such trends are likely to positively affect the head and neck cancer diagnostic market by spurring new solutions, increasing diagnostic accuracy, and enabling individualized treatment. Shortly, the integration of new technologies and collaborations is expected to improve clinical outcomes and transform cancer care.

Recent Developments in the Head and Neck Cancer Diagnostic Market

The market for head and neck cancer diagnosis has undergone significant changes, leading to improved detection, accuracy, and patient management. Notable changes include technological advancements, regulatory approvals, and research collaborations.

• Regulatory Approvals for Biomarkers: The recent FDA approvals of new biomarkers for head and neck cancers are promoting the diagnosis of these cancers. These tests are useful not only for tumor identification but also for assessing specific tumor features, aiding in the early administration of appropriate treatments, and improving clinical outcomes.
• Imaging Technologies Upgrading: Advanced imaging technologies, such as 3D imaging and hybrid PET/CT scans, are now part of routine diagnostic practice, enabling precise diagnosis of head and neck cancers. These technologies improve treatment planning and monitoring for patients with head and neck tumors.
• Designing Liquid Biopsies: Liquid biopsy test kits have revolutionized the prospects of diagnosing head and neck tumors. They allow for earlier cancer detection and enable treatment response assessments through simple blood tests instead of invasive procedures.
• The Role of AI in Cancer Diagnosis: The application of artificial intelligence in imaging interpretation is increasing. AI algorithms can process vast amounts of imaging data with high accuracy, spotting tumors and minimizing human error, thus enhancing diagnostic effectiveness.
• Telehealth Services: Telehealth services are improving access to diagnostic consultations, especially in rural areas. This approach provides efficient care, reducing the need for patients to visit healthcare facilities.

These trends are transforming the head and neck cancer diagnostic market by enhancing diagnostic accuracy, expanding access to cancer treatment, and enabling customized therapies. Over time, technological advancements are expected to further improve patient outcomes.

Strategic Growth Opportunities for Head and Neck Cancer Diagnostic Market

The head and neck cancer diagnostic market offers various growth opportunities across multiple applications. Understanding these opportunities helps stakeholders choose areas for investment and development.

• Molecular Diagnostics: The growing demand for molecular diagnostic tests offers a significant opportunity in the market. These tests enable early detection and classification of head and neck cancers, providing critical information needed for effective treatment.
• AI-Enhanced Imaging Solutions: Healthcare professionals require AI-enhanced imaging solutions that improve diagnostic accuracy. These technologies have high potential and can be developed and marketed to enhance diagnostic efficiency and patient management.
• Liquid Biopsy Applications: Expanding the use of liquid biopsy applications can drive revenue growth. Non-invasive tests for early-stage diagnosis and treatment evaluation are rapidly emerging, benefiting both patients and service providers.
• Telehealth Integration: The integration of telehealth offers an authentic growth opportunity by providing diagnostic services remotely. Expanding the market for remote diagnostic tools can improve patient care, especially in distant locations.
• Initiatives for Collaborative Research: Collaboration between academic and clinical research institutions can lead to faster development of marketable diagnostic tools and techniques. These initiatives can help companies become more competitive in the market.

These strategic growth opportunities address emerging gaps in the head and neck cancer diagnostic market, allowing stakeholders to foster innovative solutions that enhance patient management and competitiveness.

Head and Neck Cancer Diagnostic Market Driver and Challenges

The major drivers in the market include advancements in diagnostic technology, increasing public awareness of cancer screening and treatment, and higher healthcare budgets. Challenges include regulatory hurdles, expensive diagnostic methods, and the lack of certain technologies in some regions.

The factors driving the head and neck cancer diagnostic market include:

• Technological Advancements: The diagnostic services market is evolving with continuous advancements in both established and emerging molecular-based tests. These developments improve the efficiency and timing of head and neck cancer diagnoses, leading to increased demand for diagnostic procedures.
• Expanding the Scope of Cancer Education: Public health campaigns have increased awareness about the early detection of cancers, including head and neck cancer. This is encouraging more people to undergo screenings and diagnostics.
• Increasing Healthcare Spending: Emerging markets are increasing healthcare spending, enabling investments in diagnostic tools. Healthcare institutions in these markets are acquiring new diagnostic equipment, improving access to quality healthcare, and facilitating market growth.
• Geriatric Population: The aging population is contributing to a rise in head and neck cancer prevalence. As the elderly population grows, the demand for diagnostic services increases, further driving market growth.
• Targeted Therapy Programs: As more targeted therapies are developed, the demand for advanced diagnostic tools that match these therapies is increasing. Diagnosing cancers based on each patient's specific health condition will drive the need for tailored diagnostic tools.

Challenges in the head and neck cancer diagnostic market include:

• Advanced Diagnostic Tools are Costly: New diagnostic devices are often expensive, limiting their use in resource-poor areas. This can result in delays in diagnosis and treatment, leading to poorer recovery outcomes.
• Challenges Associated with Regulatory Compliance: Navigating complex regulations in the diagnostic market can be daunting for companies. Compliance with various standards and laws can be costly and delay the market entry of new products.
• Limited Reach to Advanced Diagnostic Technologies: Access to advanced diagnostic technology is limited in many areas, particularly in developing countries. This can result in lower early detection rates and reduced care quality, which needs to be addressed through relevant solutions.

The head and neck cancer diagnostic market is shaped by both enablers and obstacles. Understanding these factors is crucial for stakeholders to offer solutions that meet market needs while taking advantage of growth opportunities.

List of Head and Neck Cancer Diagnostic Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies head and neck cancer diagnostic companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the head and neck cancer diagnostic companies profiled in this report include-

• GE Healthcare
• Philips
• Siemens Healthineers
• Merck
• Eli Lilly

Head and Neck Cancer Diagnostic by Segment

The study includes a forecast for the global head and neck cancer diagnostic market by type, diagnosis, treatment, end use, and region.

Head and Neck Cancer Diagnostic Market by Type [Analysis by Value from 2019 to 2031]:

• Laryngeal Cancer
• Pharyngeal Cancer
• Salivary Gland Cancer
• Lip & Oral Cavity Cancer
• Nasopharyngeal Cancer
• Others

Head and Neck Cancer Diagnostic Market by Diagnosis [Analysis by Value from 2019 to 2031]:

• Bioscopy Screening Tests
• Blood Tests
• Dental Diagnosis
• Imaging
• Endoscopy

Head and Neck Cancer Diagnostic Market by Treatment [Analysis by Value from 2019 to 2031]:

• Chemotherapy
• Radiation Therapy
• Targeted Therapy
• Surgery
• Others

Head and Neck Cancer Diagnostic Market by End Use [Analysis by Value from 2019 to 2031]:

• Hospitals
• Ambulatory Surgical Centers
• Diagnostic Centers
• Others

Head and Neck Cancer Diagnostic Market by Region [Analysis by Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Head and Neck Cancer Diagnostic Market

The head and neck cancer diagnostic market is making significant progress due to technological advancements, rising demand for cancer diagnosis, and increased awareness about early detection. The United States, China, Germany, India, and Japan are investing in R&D to advance diagnostic techniques for head and neck cancer. These developments aim to improve healthcare quality by enhancing diagnostic accuracy, reducing costs, and enabling timely action.

• United States: Advances in molecular diagnosis and liquid biopsy strategies are revolutionizing the diagnosis of head and neck cancer. The development of targeted therapies and improvements in diagnostic imaging technologies, such as artificial intelligence, are also enhancing diagnostic accuracy and efficiency.
• China: China's growing healthcare investment is driving innovations in cancer diagnosis, particularly for head and neck cancers. New imaging devices, such as advanced CT scanners, are being adopted, and there is a strong focus on the development of genetic testing kits for screening cancer susceptibility.
• Germany: Germany is making significant strides in creating accurate diagnostic tools for head and neck cancers. New research emphasizes the use of directed imaging radionics to increase sensitivity to early tumor changes, while collaborative efforts between universities and healthcare companies are developing innovative biopsy techniques.
• India: Efforts in India are focused on improving the accessibility of head and neck cancer diagnostic services, especially in rural areas. Initiatives such as telemedicine and mobile health services aim to improve access, while cost-effective diagnostic studies are being conducted to create affordable screening tests.
• Japan: Japan is at the forefront of head and neck cancer management, with advanced imaging systems incorporated into diagnostic practices. Combined imaging modalities like PET-CT are improving diagnostic efficacy, while targeted therapy development based on cancer genomics is enhancing personalized medicine in the country.

Features of the Global Head and Neck Cancer Diagnostic Market

Market Size Estimates: Head and neck cancer diagnostic market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.

Segmentation Analysis: Head and neck cancer diagnostic market size by various segments, such as by type, diagnosis, treatment, end use, and region in terms of ($B).

Regional Analysis: Head and neck cancer diagnostic market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, diagnosis, treatments, end uses, and regions for the head and neck cancer diagnostic market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the head and neck cancer diagnostic market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this market or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the head and neck cancer diagnostic market by type (laryngeal cancer, pharyngeal cancer, salivary gland cancer, lip & oral cavity cancer, nasopharyngeal cancer, and others), diagnosis (bioscopy screening tests, blood tests, dental diagnosis, imaging, and endoscopy), treatment (chemotherapy, radiation therapy, targeted therapy, surgery, and others), end use (hospitals, ambulatory surgical centers, diagnostic centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Head and Neck Cancer Diagnostic Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031

• 3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
• 3.2. Global Head and Neck Cancer Diagnostic Market Trends (2019-2024) and Forecast (2025-2031)
• 3.3: Global Head and Neck Cancer Diagnostic Market by Type
  • 3.3.1: Laryngeal Cancer
  • 3.3.2: Pharyngeal Cancer
  • 3.3.3: Salivary Gland Cancer
  • 3.3.4: Lip & Oral Cavity Cancer
  • 3.3.5: Nasopharyngeal Cancer
  • 3.3.6: Others
• 3.4: Global Head and Neck Cancer Diagnostic Market by Diagnosis
  • 3.4.1: Bioscopy Screening Tests
  • 3.4.2: Blood Tests
  • 3.4.3: Dental Diagnosis
  • 3.4.4: Imaging
  • 3.4.5: Endoscopy
• 3.5: Global Head and Neck Cancer Diagnostic Market by Treatment
  • 3.5.1: Chemotherapy
  • 3.5.2: Radiation Therapy
  • 3.5.3: Targeted Therapy
  • 3.5.4: Surgery
  • 3.5.5: Others
• 3.6: Global Head and Neck Cancer Diagnostic Market by End Use
  • 3.6.1: Hospitals
  • 3.6.2: Ambulatory Surgical Centers
  • 3.6.3: Diagnostic Centers
  • 3.6.4: Others

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

• 4.1: Global Head and Neck Cancer Diagnostic Market by Region
• 4.2: North American Head and Neck Cancer Diagnostic Market
  • 4.2.1: North American Market by Diagnosis : Bioscopy Screening Tests, Blood Tests, Dental Diagnosis, Imaging, and Endoscopy
  • 4.2.2: North American Market by End Use: Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, and Others
• 4.3: European Head and Neck Cancer Diagnostic Market
  • 4.3.1: European Market by Diagnosis : Bioscopy Screening Tests, Blood Tests, Dental Diagnosis, Imaging, and Endoscopy
  • 4.3.2: European Market by End Use: Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, and Others
• 4.4: APAC Head and Neck Cancer Diagnostic Market
  • 4.4.1: APAC Market by Diagnosis : Bioscopy Screening Tests, Blood Tests, Dental Diagnosis, Imaging, and Endoscopy
  • 4.4.2: APAC Market by End Use: Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, and Others
• 4.5: ROW Head and Neck Cancer Diagnostic Market
  • 4.5.1: ROW Market by Diagnosis : Bioscopy Screening Tests, Blood Tests, Dental Diagnosis, Imaging, and Endoscopy
  • 4.5.2: ROW Market by End Use: Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Head and Neck Cancer Diagnostic Market by Type
  • 6.1.2: Growth Opportunities for the Global Head and Neck Cancer Diagnostic Market by Diagnosis
  • 6.1.3: Growth Opportunities for the Global Head and Neck Cancer Diagnostic Market by Treatment
  • 6.1.4: Growth Opportunities for the Global Head and Neck Cancer Diagnostic Market by End Use
  • 6.1.5: Growth Opportunities for the Global Head and Neck Cancer Diagnostic Market by Region
• 6.2: Emerging Trends in the Global Head and Neck Cancer Diagnostic Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Head and Neck Cancer Diagnostic Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Head and Neck Cancer Diagnostic Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: GE Healthcare
• 7.2: Philips
• 7.3: Siemens Healthineers
• 7.4: Merck
• 7.5: Eli Lilly